Dr Ian Storer

Dr Ian Storer is the head of Hit Discovery and Head of Chemistry in Discovery Sciences at AstraZeneca. The Hit Discovery department consists of High Throughput Screening (HTS), Fragment Based Lead Generation (FBLG), DNA-encoded Library screening (DEL), Virtual Screening (VS) and PROTAC hit-finding, plus hit-to-lead chemistry to support integrated lead discovery for projects across all of the company therapeutic areas of focus. His current research spans the fields of medicinal chemistry, organic synthesis, chemical biology and protein degradation. Prior to joining AstraZeneca in 2016, he spent 10 years as a medicinal chemist with Pfizer supporting lead to candidate projects working across multiple target classes in several disease areas, including enzymes, receptors, solute carriers and ion channels. Before entering industry, he earned his Ph.D. from the University of Cambridge with Professor Steven V. Ley working on natural product total synthesis. This was followed by postdoctoral research fellowship at Caltech working with Professor David W. C. MacMillan on the development of new methods for enantioselective organocatalysis. He is an author or inventor on over 70 patent applications and publications.